MBI

Mary Stanfill Joins ICD10monitor

Retrieved on: 
Tuesday, December 21, 2021
WHO, News, International Classification of Diseases, Teijin, List of international sports federations, Education, Population health, Joint Monitoring and Implementation Committee, World, World Health Organization, CDI, CCS, Classification, EIC, Knowledge Organization (journal), ICD-10, MBI

SAINT PAUL, Minn., Dec. 21, 2021 /PRNewswire-PRWeb/ --We here at ICD10monitor and Talk Ten Tuesdays are proud to announce that Mary H. Stanfill, MBI, RHIA, CCS, CCS-P, FAHIMA, will be the new ICD-11 correspondent for ICD10monitor and Talk Ten Tuesdays.

Key Points: 
  • SAINT PAUL, Minn., Dec. 21, 2021 /PRNewswire-PRWeb/ --We here at ICD10monitor and Talk Ten Tuesdays are proud to announce that Mary H. Stanfill, MBI, RHIA, CCS, CCS-P, FAHIMA, will be the new ICD-11 correspondent for ICD10monitor and Talk Ten Tuesdays.
  • Chuck Buck, publisher of ICD10monitor and executive producer of Talk Ten Tuesdays, made the announcement this week.
  • Buck noted that Stanfill was recommended to the role by Margaret Skurka who held a similar role for several years as the ICD-11 correspondent.
  • ICD10monitor reports on current issues including population health, physician engagement, and the patient experience.

AM Best Affirms Credit Ratings of Provident Insurance Corporation Limited

Retrieved on: 
Thursday, December 9, 2021
Professional Services, Insurance, Finance, Risk, PMV, Growth, Motor vehicle, Credit, MBI, News, Industry, ALL, AM, Insurance, ERM, COVID-19, AM Best, Risk management, Communication, Data

AM Best has affirmed the Financial Strength Rating of B (Fair) and the Long-Term Issuer Credit Rating of bb+ (Fair) of Provident Insurance Corporation Limited (PICL) (New Zealand).

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of B (Fair) and the Long-Term Issuer Credit Rating of bb+ (Fair) of Provident Insurance Corporation Limited (PICL) (New Zealand).
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .
  • AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry.

Iron Creek Leads Recapitalization of Midwest Backgrounds, Inc.

Retrieved on: 
Friday, December 3, 2021
Finance, Professional Services, Technology, Software, Human Resources, Principal, Consumer, Company, Partnership, MBI, Leadership, History, Software, Credit, Growth, Management

Iron Creek Partners LLC ( Iron Creek ), a private investment firm based in Santa Fe, NM, today announced the recapitalization of Midwest Backgrounds, Inc. (MBI, MBI Worldwide , or the Company), a leading Consumer Reporting Agency offering employment background screening solutions to small, medium, and large corporations across the United States.

Key Points: 
  • Iron Creek Partners LLC ( Iron Creek ), a private investment firm based in Santa Fe, NM, today announced the recapitalization of Midwest Backgrounds, Inc. (MBI, MBI Worldwide , or the Company), a leading Consumer Reporting Agency offering employment background screening solutions to small, medium, and large corporations across the United States.
  • Iron Creek led the investment group, which included MBIs management team and Main Street Capital Corporation.
  • Iron Creek has a history of supporting growing companies like ours, and I feel confident that under their guidance and leadership, we are in good hands.
  • Iron Creek seeks to partner with strong management teams and to support its portfolio companies growth by leveraging its network of relationships and its sector experience.

Fintech Startup “nxtCRE” Launches Revolutionary Sales Platform for CRE

Retrieved on: 
Tuesday, November 30, 2021
Professional Services, Data Management, Technology, Commercial Building & Real Estate, Software, Finance, Construction & Property, Partnership, MBI, Pressure, CRE, Time, Security (finance), Real estate

Julian Henkin, a nxtCRE founding team member, added, “We match MBI with the exact properties or offerings they want from sellers, funds seeking equity, or developers looking for investors. We grant sellers free listings on our nxtCRE platform, and like a smart dating site, match them with MBI. At which point the two parties can choose to come together---and it all happens within a few days.”

Key Points: 
  • Thanks to our exclusive partnerships with major lenders across the nation, we associate with MBI before they even enter the market.
  • Ken Griggs, a nxtCRE founding team member and its lender liaison, said, For lenders, an exclusive partnership with nxtCRE allows them to earn additive revenue and originate more loans; its a win-win.
  • We grant sellers free listings on our nxtCRE platform, and like a smart dating site, match them with MBI.
  • Miami-based nxtCRE began rolling out with the launch of their website and platform today, at www.nxtcre.com
    View source version on businesswire.com: https://www.businesswire.com/news/home/20211130006035/en/

Marrone Bio Achieves Excellent Climate Impact Score for Venerate® XC Bioinsecticide

Retrieved on: 
Wednesday, November 17, 2021
Private Securities Litigation Reform Act, GHG, MITES, MBII, Carbon, Adoption, Review, Safety, Movement, Security (finance), Sale, Seed, Technology, Veneration, Industry, Climate, Forward-looking statement, Soil, Crop protection, Toxicity, IPCC, MBI, Human, Soybean, U.S. Securities and Exchange Commission, Tree, Agriculture, COVID-19, Twitter, Research, GLOBE, LCA, Marketing, Instagram, Social media, Electricity, Ecosystem, LinkedIn, Steam, Farmer, Nut, Natural Resources, CROI, NASDAQ, Vegetable

One of the key learnings from this product analysis was the amount of electricity and steam required to produce Venerate XC.

Key Points: 
  • One of the key learnings from this product analysis was the amount of electricity and steam required to produce Venerate XC.
  • The products low toxicity is also demonstrated in its safety to humans and aquatic life, key attributes that allowed Venerate XC to score an 8.6 out of 10 on climate impact.
  • Venerate XC Bioinsecticide , a top revenue-generator for Marrone Bio, is a novel, broad spectrum proprietary microbe (Burkholderia rinojensis strain A396) that is active against a wide range of yield-robbing insects and mites.
  • This is the second climate impact study Marrone Bio has conducted with the help of Boundless Impact Research & Analytics.

Instem Expands In Silico Toxicology Service To Meet Growing Demand

Retrieved on: 
Monday, November 22, 2021
Technology, Biotechnology, FDA, Health, Other Health, Pharmaceutical, Other Science, Other Technology, Research, Software, General Health, Science, Data Management, Clinical Trials, ICH, Guideline, Technology, Compliance, Chemical safety, MBI, Electronic common technical document, Solution, Abuse, Informatics, SD, US, Research, EMA, Organization, Knowledge, FDA, Toxicology, Classification, CNS, Toxicity, Life, Liver, Chemistry, Medical device, Risk management

Instem , a leading provider of IT solutions and services to the global life sciences market, announced today that it has further enhanced its Predict In Silico Toxicology service portfolio by adding four new services.

Key Points: 
  • Instem , a leading provider of IT solutions and services to the global life sciences market, announced today that it has further enhanced its Predict In Silico Toxicology service portfolio by adding four new services.
  • Since its successful launch in December 2020 , Instem has seen strong interest in the Predict service from clients across the globe.
  • These latest service offerings have been developed to address new regulatory guidance and will deliver further efficiencies and increased regulatory compliance for clients.
  • Instem supports its global roster of clients through offices in the United States, United Kingdom, France, Switzerland, Japan, China, and India.

DGAP-News: Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation

Retrieved on: 
Tuesday, November 2, 2021
Sanford Burnham Prebys Medical Discovery Institute, Penny Stamps Distinguished Speaker Series, Blood, Victoria, MBI, Vaccination, Patient, FDA, Foundation, FIA, Infection, Distinguishing, COVID-19, Privacy, Nasdaq, Immune system, School, Immunity, Pharmaceutical industry, Vaccine

Quidel Corporation announced today that it will serve as sponsor for the upcoming Distinguished Speaker Series being conducted by the Bay Area Lyme Foundation.

Key Points: 
  • Quidel Corporation announced today that it will serve as sponsor for the upcoming Distinguished Speaker Series being conducted by the Bay Area Lyme Foundation.
  • Quidel is a California-based diagnostic health care manufacturer known for successfully developing rapid diagnostic health solutions, including the industry-leading Sofia(R) 2 Lyme FIA test for Lyme disease.
  • The Distinguished Speaker Series are free community events that provide new information on various Lyme-related topics.
  • 'We share the Bay Area Lyme Foundation's mission to make Lyme disease easy to diagnose and simple to cure,' said Judi Tilghman, Ph.D., vice president of technology assessment at Quidel.

Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation

Retrieved on: 
Tuesday, November 2, 2021
Medical Devices, Health, Infectious Diseases, Other Science, Research, Science, Sanford Burnham Prebys Medical Discovery Institute, Corporation, Penny Stamps Distinguished Speaker Series, Blood, Victoria, MBI, Vaccination, Patient, Foundation, FIA, Infection, Distinguishing, COVID-19, Privacy, Nasdaq, School, Immunity, Pharmaceutical industry, Vaccine

Quidel Corporation announced today that it will serve as sponsor for the upcoming Distinguished Speaker Series being conducted by the Bay Area Lyme Foundation.

Key Points: 
  • Quidel Corporation announced today that it will serve as sponsor for the upcoming Distinguished Speaker Series being conducted by the Bay Area Lyme Foundation.
  • Quidel is a California-based diagnostic health care manufacturer known for successfully developing rapid diagnostic health solutions, including the industry-leading Sofia 2 Lyme FIA test for Lyme disease.
  • The Distinguished Speaker Series are free community events that provide new information on various Lyme-related topics.
  • We share the Bay Area Lyme Foundations mission to make Lyme disease easy to diagnose and simple to cure, said Judi Tilghman, Ph.D., vice president of technology assessment at Quidel.

Marrone Bio Submits Regulatory Packages for Nematicides/Insecticides in United States and Brazil

Retrieved on: 
Monday, November 1, 2021
Online, IBAMA, Research, LinkedIn, ANVISA, China Biologic Products, Environment, MBI, MBII, Twitter, Security (finance), U.S. Securities and Exchange Commission, Adoption, NASDAQ, Private Securities Litigation Reform Act, Crop protection, Ministry, EPA, Brazilian Health Regulatory Agency, Review, Leadership, Social media, Forward-looking statement, Marketing, Daniel Grant, Instagram, Tree, Brazilian Institute of Environment and Renewable Natural Resources, Movement, Ministry of Agriculture (Azerbaijan), COVID-19, Nut, Soybean, Institute, GLOBE, Vegetable, Sale, Risk management

With estimated peak potential revenue in excess of $100 million for both products, MBI-306 and its variants and MBI-206 will be important contributors to advancing Marrone Bios growth and leadership in crop bioprotection.

Key Points: 
  • With estimated peak potential revenue in excess of $100 million for both products, MBI-306 and its variants and MBI-206 will be important contributors to advancing Marrone Bios growth and leadership in crop bioprotection.
  • MBI-206 has been submitted for approval in Brazil for two uses: as a seed treatment and as a foliar/in-furrow product.
  • The companys commercial products are sold globally and supported by a robust portfolio of more than 500 issued and pending patents.
  • Additional information that could lead to material changes in the companys performance is contained in its filings with the Securities and Exchange Commission.

Janice Innis-Thompson Elected to MBIA Inc.'s Board of Directors

Retrieved on: 
Thursday, October 28, 2021
Finance, Banking, Professional Services, Other Professional Services, Insurance, MBIA, Compliance, University, Wardlaw-Hartridge School, National Forest Foundation, University of Florida, MBI, Nationwide, TIAA, Security (finance), U.S. Securities and Exchange Commission, Private Securities Litigation Reform Act, Compte rendu, NYSE, Public relations, Senior, Annual report, National, Company, Hale House, COVID-19, Compensation, Corporate litigation in the United Kingdom, BS, Employment, Coronavirus, Audit, Management

MBIA Inc. (NYSE:MBI) (the Company) today announced that yesterday, Wednesday, October 27, 2021, Ms. Janice Innis-Thompson (55) was elected to the Companys Board of Directors, where she will also serve as a member of the Audit; Finance and Risk; and Compensation and Governance Committees.

Key Points: 
  • MBIA Inc. (NYSE:MBI) (the Company) today announced that yesterday, Wednesday, October 27, 2021, Ms. Janice Innis-Thompson (55) was elected to the Companys Board of Directors, where she will also serve as a member of the Audit; Finance and Risk; and Compensation and Governance Committees.
  • She has also served on Boards for Bridge Builder Mutual Fund, an Edward Jones Complex; The Wardlaw-Hartridge School; Board IQ; New York Police Department Audit Advisory Board; and Hale House.
  • We are pleased that Janice has accepted our invitation to join the MBIA Board, said Charles Rinehart, Chairman of the MBIA Inc. Board of Directors.
  • We are confident that Janices legal and compliance experience will contribute positively to our efforts to enhance MBIA Inc.s shareholder value.